Literature DB >> 10102429

Motor system excitability in patients with restless legs syndrome.

F Tergau1, S Wischer, W Paulus.   

Abstract

In 18 patients with idiopathic restless legs syndrome (RLS), intracortical inhibition by paired transcranial magnetic stimulation (TMS) was significantly reduced for both foot and hand muscles, suggesting that the entire motor cortex is disinhibited in RLS. Decreased intracortical facilitation in the foot muscle but not in the hand muscle may be due to subliminal activation of the symptomatic lower limbs. Motor excitability measurements of single TMS were not altered. These results support a subcortical origin of RLS.

Entities:  

Mesh:

Year:  1999        PMID: 10102429     DOI: 10.1212/wnl.52.5.1060

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

Review 2.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Restless Leg Syndrome and Periodic Limb Movements of Sleep.

Authors:  Mark W. Mahowald
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

4.  Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission.

Authors:  César Quiroz; Virginia Pearson; Seema Gulyani; Richard Allen; Christopher Earley; Sergi Ferré
Journal:  Exp Neurol       Date:  2010-04-10       Impact factor: 5.330

5.  Targeting hypersensitive corticostriatal terminals in restless legs syndrome.

Authors:  Gabriel Yepes; Xavier Guitart; William Rea; Amy H Newman; Richard P Allen; Christopher J Earley; César Quiroz; Sergi Ferré
Journal:  Ann Neurol       Date:  2017-12-07       Impact factor: 10.422

Review 6.  Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Authors:  Christopher J Earley; George R Uhl; Stefan Clemens; Sergi Ferré
Journal:  Sleep Med       Date:  2016-06-27       Impact factor: 3.492

Review 7.  Sleep-related non epileptic motor disorders.

Authors:  Pasquale Montagna
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

8.  Idiopathic restless legs syndrome: abnormalities in central somatosensory processing.

Authors:  Jörn Schattschneider; Andre Bode; Gunnar Wasner; Andreas Binder; Günther Deuschl; Ralf Baron
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 9.  Restless legs syndrome-current therapies and management of augmentation.

Authors:  Claudia Trenkwalder; Juliane Winkelmann; Yuichi Inoue; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

10.  Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome.

Authors:  Raffaele Ferri; Filomena I I Cosentino; Mauro Manconi; Francesco Rundo; Oliviero Bruni; Marco Zucconi
Journal:  Sleep       Date:  2014-08-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.